Objectives: Inflammatory bowel disease states are associated with gastrointestinal dysbiosis. Mucosal biopsy sampling, retrieving the bacterial community that most directly interacts with the host, is an invasive procedure that, we hypothesis, may be sufficiently approximated by other sampling methods. We investigate the relatedness of samples obtained by different methods and the effects of bowel preparation on the gastrointestinal community in a paediatric population. Methods: We recruited a cohort of patients undergoing colonoscopy, collecting serial samples via differing methods (rectal swabs, biopsies, and faecal matter/luminal contents) prebowel preparation, during colonoscopy and after colonoscopy. Next-generation sequencing was used to determine the structure of the microbial community. Results: The microbial community in luminal contents collected during colonoscopy was found to be more similar to that of mucosal biopsies than rectal swabs. Community traits of the mucosal biopsies could be used to segregate patients with inflammatory bowel disease from other patients, and the similarity of the communities in the luminal contents was sufficient for the segregation to be reproduced. Microbial communities sampled by rectal swabs and prebowel preparation faeces were less similar to mucosal biopsies. Bowel preparation was found to have no significant long-term effects on the microbial community, despite the transient effects evident during colonoscopy. Conclusions: A clinically relevant description of the mucosal microbial community can be obtained via the noninvasive collection of luminal contents after bowel cleansing. Bowel preparation in a paediatric population results in no consistent sustained alterations to the gastrointestinal microbiota.
H
umans carry approximately 10 11 bacterial organisms per gram of faecal material in their gastrointestinal tract alone (1) , collectively known as the gastrointestinal microbiota. The coevolution of the human body and its gut microbiota has led to a taxonomically diverse ecosystem, which not only differs greatly between individuals but also varies within individuals throughout their lifetime. Analytical advances due to the Human Microbiome Project have helped increase our knowledge of specific crucial species in the microbiota. Research into to the colonic microbiota suggests changes and imbalances in this relation may result in disease states. There is increasing evidence to suggest an association between dysbiosis of the gut microbiota and disease states, most notably inflammatory bowel disease (IBD), colorectal cancer, and obesity (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) .
The gut microbiota can be sampled by a rectal mucosal biopsy, faecal matter/luminal contents, or rectal swab, but which is most representative? All 3 methods have distinct advantages and disadvantages when practiced in paediatric populations. Currently, the criterion standard for colonic analysis is a rectal biopsy of the mucosal layer which, as well as providing tissue for histological
What Is Known
Altered gastrointestinal microbiota states have been associated with inflammatory bowel disease. Bowel preparation in nonpaediatric populations has little long-term effects on the gastrointestinal microbiota. Rectal swabs taken from unprepared individuals provide notably different observations of the gastrointestinal microbiota when compared to mucosal biopsies.
What Is New
Luminal contents (post-bowel preparation) provide the closest approximation of the mucosal microbiota; rectal swabs and faecal samples taken before preparation are more disparate. This similarity is sufficient to segregate patients with inflammatory bowel disease from other patients requiring endoscopies. Bowel preparation in paediatric populations produces significant shifts in community structure and diversity evident during colonoscopy, and these effects are transient.
analysis, identifies the mucosal adherent bacteria. These bacteria interact directly with the host immune system and are thus potentially able to modulate the manifestation of diseases such as IBD. A biopsy, however, requires a colonoscopy or sigmoidoscopy, often performed under general anaesthesia for children, which itself carries risks. Where the interest is in the microbiota, bacterial populations and diversity can also be assessed in faecal matter or rectal swabs. Faecal matter sampling is noninvasive and easy, although patients dislike handling faeces and especially where sampling is requested at home, compliance is often poor. Rectal swabbing is noninvasive, less expensive, less time consuming, and more comfortable and acceptable for both adult and paediatric patients, so this might be an ideal sampling method; however, the extent to which either approach provides information comparable to mucosal biopsy is unknown.
We hypothesize that rectal swabbing and/or faecal sampling may be suitable, noninvasive alternatives to a mucosal biopsy for sampling the gut microbiota. To test this we assessed concordance in composition and diversity of the microbiota retrieved by these methods from a paediatric cohort of patients compared to results obtained from a rectal mucosal biopsy sample. We investigated the effect of laxative bowel preparation on the composition and diversity of the gut microbiota, as studies have shown this to be perturbed by bowel cleansing.
MATERIALS AND METHODS

Study Populations
The study population comprised paediatric patients undergoing sigmoidoscopy or colonoscopy in our unit between February and June 2014 for any clinical indication. There were no exclusion criteria. Thirty-one patients were recruited, with samples obtained from 18 of these, ages between 4 and 17 years. Sixteen patients provided a full set of samples (swab, biopsy, and faecal sample) at colonoscopy. Clinical metadata and sample availability for the patients who provided samples are shown in Table 1 .
Colonoscopy patients received standard bowel preparation of sodium picosulphate with magnesium citrate and senna before their procedure as per local protocol (Supplemental Digital Content 1, http://links.lww.com/MPG/A662). Sigmoidoscopy was performed on an unprepared colon. All patients underwent the procedures under general anaesthesia.
Ethics Declaration
Written consent was obtained from parents of all study participants before any sample collection and ethical approval was granted by Chelsea Research Ethics Service, United Kingdom (IRAS REC number 12/LO/0240).
Sample Collection
In order to achieve a longitudinal representation of the gut microbiota a total of 6 samples were collected from each participant at 3 different time points ( Fig. 1) : precolonoscopy, colonoscopy, and postcolonoscopy. The precolonoscopy faecal sample was obtained before bowel preparation. A rectal swab, biopsy, and luminal contents were taken at colonoscopy. The postcolonoscopy faecal sample was obtained at a subsequent outpatient visit 2 weeks or more after the procedure. Samples collected for each patient are indicated in Table 1 . 
Faecal Sample Collection
Precolonoscopy faecal samples were collected by the patient before beginning bowel preparation. Luminal contents were obtained at colonoscopy, either directly or via colonoscopic suction. In all cases the faecal liquid present at the most distal colonic location was sampled. The samples were stored in a DNase, RNase free, sterile microcentrifuge, tube and stored at À808C.
Mucosal Biopsy Collection
Rectal mucosal biopsies were obtained during colonoscopy using disposable flexible biopsy forceps and were stored in a DNase, RNase free, sterile microcentrifuge tube at À808C.
Rectal Swab Collection
Rectal swabs were taken at colonoscopy and postcolonoscopy. The swab specimen was collected by inserting a sterile cotton-tipped swab just beyond the anal canal and rotating once. Swabs were then removed and stored at À808C.
Bacterial DNA Extraction
Faecal samples (200 mg) were processed using the FastDNA SPIN Kit for Soil (MP Biomedicals, Solon, OH), incorporating a beadbeating step for mechanical disruption of cells. Extractions were performed following the manufacturer's protocol except that the final elution step was into TRIS (10 mmol/L) low-ethylenediaminetetraacetic acid (0.1 mmol/L) buffer. Swabs underwent the same extraction process, with swab heads being removed with sterilized scissors. Biopsy samples (a maximum of 500 mg) were placed in the FastDNA SPIN Kit for Soil LME tubes and homogenized twice using FastPrep-24 (MP Biomedicals) for 40 seconds at maximum setting. Samples were incubated at 378C for 10 minutes on a rotator then incubated for 18 hours at 558C with 100 mL of 20 mg/mL proteinase K. After the incubation, samples were heated to 908C for 1 hour and then entered the faecal sample extraction process as above.
Polymerase Chain Reaction Amplification and Pyrosequencing of Variable Regions of the Bacterial 16S rRNA Gene
The V3-V5 region of the bacterial 16S rRNA genes was amplified from each DNA sample using a primer pair tagged with individually unique 12-bp error-correcting Golay barcodes (12) (13) (14) . Polymerase chain reaction (PCR) was performed as previously described (15) . Replicate amplicons were pooled and purified, and 2 pyrosequencing runs were performed on a 454 Life Sciences GS Junior (Roche, Basel, Switzerland) following the Roche Amplicon Lib-L protocol. Replicate samples spread over all sequencing runs acted as internal controls. Negative controls were included in all sequencing runs to identify potential contamination.
Bioinformatics
454 Shotgun processed data were denoized using AmpliconNoise (16) as part of the ''Quantitative Insights Into Microbial Ecology'' (17) package followed by chimera removal with Perseus (16) and demultiplexing. Sequences were aligned using the SILVA rRNA database 119 (18) release for reference and clustered at 97% sequence identity using the UCLUST algorithm (19) into operational taxonomic units (OTUs). The OTU table was filtered to remove singletons (sequences present only once in the dataset) and OTUs only present in 1 sample. Rarefaction to 556 reads was performed, removing heterogeneity of sequencing reads per sample. The OTU table was summarized to genus and phylum level using the Quantitative Insights Into Microbial Ecology script summarize_taxa.py, with the resulting taxonomic descriptors being referred to as ''taxonomic groups''. In order to calculate generalized UniFrac Distances (20) , a taxonomic tree was created based on consensus sequences for each genus-level classification. The consensus sequences created using the EMBOSS cons tool (21) , combining the representative sequences for the OTUs that were compressed into each classification.
Data Availability
16S rRNA amplicon data have been deposited at the European Nucleotide Archive under accession number PRJEB11439.
Statistics
Statistical analysis was performed using the R software package (version 3.1.3).
Alpha diversity has been calculated using the ShannonWeaver index and has been analysed for the filtered OTU table. Alpha diversity was analysed using the Wilcoxon signed-rank test, Mann-Whitney U test, or the Friedman test.
Where taxonomic group count data are presented, it is drawn from either the genus or phylum-level summarized tables. The stacked barcharts presented are those derived from the genus-level summarized table. General linear models (GLM), implementing a negative binomial regression, and including sample donor ID and age as additional variables where applicable, were used to detect associations across the datasets.
Generalized UniFrac distances were calculated using the summarized OTU table and were compared using the Wilcoxon signed-rank test, Mann-Whitney U test, or a Kruskal-Wallis ANOVA.
Where post-hoc analysis or multiple tests have been performed, P values have been adjusted with the Bonferroni correction.
RESULTS
Sequencing Results
The microbial communities of 88 samples were successfully sequenced using the Roche GS Junior platform, with a total of 181,486 sequencing reads. The 13 samples with <556 reads were discarded, with rarefaction curves showing that this number of reads was sufficient to accurately capture the full microbial diversity. After the removal of duplicates, 17 biopsy samples, 16 luminal content samples and 18 swabs taken at colonoscopy, 11 prebowel preparation faecal samples, and 7 postbowel preparation faecal samples were retained, inclusive of 14 complete sets of sample taken at colonoscopy from patients who had undergone bowel preparation.
Can Luminal Contents or Swabs Taken During Colonoscopy Act as a Surrogate for Biopsy Samples?
Given the invasive nature of obtaining mucosal biopsy samples, a less invasive surrogate sample would prove valuable if observations of the microbial community are sufficiently similar. The 14 complete sets (a biopsy, a swab, and luminal contents taken at colonoscopy) from patients who had undergone a bowel preparation were compared, with the biopsy being considered the ''criterion standard'' representation of the mucosa-associated gut microbiota.
Generalized UniFrac distances, summarizing the similarity of samples according to both microbial diversity and abundance, were measured, with the distances between biopsies and paired luminal contents being significantly lower (P ¼ 0.002) than the distance between biopsies and paired swabs (paired t tests, mean distances 0.32 and 0.57, respectively). Biopsies were also found to be more similar to their paired luminal contents than to other biopsies (P < 0.001, mean distance between paired luminal contents and biopsies ¼ 0.32 faeces (n ¼ 14), and mean distance between biopsies ¼ 0.57 (n ¼ 91 comparisons made between 14 biopsies). These comparisons are shown in Figure 1 .
The diversity of the microbial communities was compared between biopsies and the surrogate samples. A Friedman test indicated significant differences between sample types (P ¼ 0.008), and although the community diversity was lower in luminal contents than paired biopsies, post-hoc analysis found this to be nonsignificant (median diversities: luminal contents ¼ 3.23, rectal swabs ¼ 4.08, biopsies ¼ 4.04; Fig. 2 ).
GLMs were then used to identify associations between sample types and taxonomic groups that comprised >1% of the dataset reads. At the genus level, compared to paired biopsies, luminal contents were found to have a significantly lower abundance of Ruminococcaceae (P ¼ 0.032) and a significantly higher abundance of Anaerostipes (P ¼ 0.026). Rectal swabs had a greater number of taxonomic groups that differed from paired biopsies, with significant decreases in 3 Lachnospiraceae taxonomic groups (P < 0.001, P ¼ 0.027, P ¼ 0.038), Bacteroides (P ¼ 0.015), Blautia (P < 0.001), and Ruminococcaceae (P < 0.001) and significant increases in Peptoniphilus and Finegoldia (P < 0.001). Comparisons of the taxonomic groups for the 14 sets of samples are shown in Figure 3 .
Differential taxonomic group abundance was also investigated at the level of phylum. GLMs indicated that rectal swabs had significantly increased abundances of Actinobacteria and fusobacteria (P < 0.001) compared to paired biopsies.
Similarity of Biopsies to Faecal Samples Taken Before Bowel Preparation
Given that luminal contents, despite the lower diversity at the time of colonoscopy, are more similar than rectal swabs to paired biopsies, we sought to determine the similarity of faecal samples taken before bowel preparation versus paired biopsy samples. Eight sets of prebowel preparation faecal samples, luminal contents, and biopsies were available. Generalized UniFrac distances between the paired biopsies and prebowel preparation faecal samples were found to be significantly lower than distances between biopsies (P ¼ 0.03, median distance ¼ 0.53 between biopsies [n ¼ 28] and 0.44 between paired biopsies and prebowel preparation faecal samples [n ¼ 8]). Biopsies were, however, significantly more similar to paired luminal contents than they were to paired precolonoscopy faecal samples (P ¼ 0.04, mean distance between paired biopsies and colonoscopy faecal samples ¼ 0.53; Fig. 4) .
Prebowel preparation faecal samples and paired biopsies did not have significantly different microbial community diversities (median diversities of 4.48 and 4.35, respectively); however, multiple taxonomic groups were found to be differentially abundant. Compared to paired biopsies, the prebowel preparation faecal samples were found to have significantly higher abundances of Ruminococcus, Bifidobacterium, Blautia, Subdoligranulum, and Peptostreptococcaceae (P < 0.001) and significantly decreased abundances of Faecalibacterium (P ¼ 0.002) and a Lachnospiraceae taxonomic group (P < 0.001). At the phylum level, Erysipelotrichia and Actinobacteria were significantly more abundant in prebowel preparation faecal samples compared to paired biopsies (P ¼ 0.010 and P < 0.001, respectively), whereas Bacteroidia and Betaproteobacteria were significantly lower in abundance (P ¼ 0.033 and P ¼ 0.006).
What Are the Effects of Bowel Preparation on the Faecal Microbiota?
To determine the effects of bowel preparation on the faecal microbiota 6 sets of patient samples were considered, each including faecal samples taken prebowel preparation, luminal contents, and postcolonoscopy faecal samples (a median of 55 days after colonoscopy).
The diversity of the microbial communities for each sample set was found to differ significantly (Friedman test, P ¼ 0.04), with lower diversity communities in luminal content samples (median prebowel preparation diversity ¼ 4.82, luminal contents diversity ¼ 4.33, and postcolonoscopy diversity ¼ 4.85), although post-hoc analysis found the differences to be nonsignificant after correction. No significant change in diversity was found comparing prebowel preparation and postcolonoscopy. GLMs were used to identify shifts in taxonomic group abundance. A significant increase in Faecalibacterium (P < 0.001) and significant decreases in Ruminococcus, Escherichia, Pseudobutyrivibrio, and Subdoligranulum (P < 0.001) were found in luminal contents when compared to prebowel preparation faecal samples. When prebowel preparation samples were, however, compared to paired postcolonoscopy samples, only minor changes in taxonomic group abundances were found (a significant increase in Christensenellaceae [P < 0.001] in the post colonoscopy samples). At the phylum level, despite some temporary changes as a result of the bowel preparation (a significant reduction in the abundance of Gammaproteobacteria [P < 0.001] and an increase in Bacteroidia (P ¼ 0.014) in luminal contents), no significant alterations were found between pre-and postbowel preparation samples. Overall, it would appear that there are relatively minor concordant changes as a result of the bowel preparation. Conversely, when considering the percentage of reads that were assigned to different genus-level taxonomic groups when comparing pre-and post-treatment samples, considerable alteration of the microbial community was observed (a median of 35% of taxonomic group reads being reassigned). Even when performed at phylum level, a median of 20% of taxonomic group reads were reassigned to different phyla. The taxonomic groups observed at genus level found in the 6 sets of patient data are shown in Figure 5 .
Are There Any Associations Between Microbial Community and Disease State?
Available samples were split into 2 groups according to the patient diagnoses made by attending clinicians; either IBD (inclusive of Crohn diseases [CD] and ulcerative colitis [UC]) or non-IBD diagnoses (Table 1) . GLMs were performed including the age of the donor patients as a confounding factor, and only patients having undergone bowel preparation were included in the analyses.
Microbial data for biopsies were available for 5 patients with CD, 5 patients with UC, and 5 non-IBD patients. Samples from patients with IBD were found to have a significantly less diverse microbial communities (P ¼ 0.005, median diversity: IBD ¼ 3.56, non-IBD ¼ 4.77). Biopsies from patients with IBD had a significantly higher abundance of Escherichia (P < 0.001) and lower abundances of Lachnospiraceae and Ruminococcus (nonsignificant after multiple testing corrections). At the phylum level, IBD biopsies were associated with a significantly higher abundance of Gammaproteobacteria (P < 0.001).
Microbial data from luminal contents were available for 5 patients with UC, 4 patients wih CD, and 5 non-IBD patients. Similar to the biopsy results, microbial community diversity was found to be significantly lower in samples from patients with IBD compared to non-IBD (P ¼ 0.029), median diversity: IBD ¼ 2.92, non-IBD ¼ 4.33. IBD luminal contents also showed significant shifts in the same taxonomic groups as the biopsies: significantly increased Escherichia (P ¼ 0.002) and lower abundances of Lachnospiraceae and Ruminococcus (nonsignificant after multiple testing corrections). Similarly, at the phylum level, IBD luminal contents were again associated with a significantly higher abundance of Gammaproteobacteria (P < 0.001).
Although a nonsignificant reduction in community diversity was evident in prebowel cleansed faecal samples (median diversity: IBD ¼ 3.61, non-IBD ¼ 4.63), no matching taxonomic group differences were evident (IBD n ¼ 5, non-IBD n ¼ 6).
The 3 significant factors found to differ between the biopsy sample groups (the Shannon-Weaver diversity index, and Escherichia and Gammaproteobacteria sequencing reads) were used to calculate a matrix of distances between samples, with the aim of discriminating between IBD and non-IBD samples. Improved separation was achieved through incorporating Lachnospiraceae and Ruminococcus sequencing reads into the calculations. The distances derived from these 5 factors were used to cluster the biopsy samples (Fig. 6A ) and the faecal samples taken at colonoscopy (Fig. 6B ) by similarity. The same factors were used to cluster prebowel preparation samples but resulted in poor separation.
DISCUSSION
We conclude that microbial community composition from rectal swabs was unrelated to rectal biopsies and luminal contents, and thus, although a noninvasive and more rapid sampling method, they do not serve as a useful surrogate for sampling the mucosaassociated microbiota. These observations were supported by AraujoPerez et al (22) who also documented the difference in bacterial community composition between swabs and biopsies. Our findings, however, suggest a concordance between the bacterial diversity and composition from rectal biopsies and luminal contents from a prepared bowel, raising the possibility of luminal contents being a viable alternative to invasive biopsies for the purpose of determining the microbial community.
This finding is given greater importance by our demonstration that measurements of the microbial community drawn from biopsy samples can be used to segregate patients with CD and UC from non-IBD patients, and that these factors can also be measured in luminal contents and result in similar clustering. This shows that not only are the samples similar, but they share enough homology to be of clinical use.
Zoetendal et al (23) found significant differences between the microbial communities of biopsies and faecal samples in adults. This is comparable to our finding of dissimilarity between biopsy sample microbiota and the pretreatment samples analysed. In our work, bowel preparation appears sufficiently to cleanse the lumen to ensure that the luminal contents sampled at colonoscopy-being derived from surface/mucus-adherent microbes rather than the bulk faecal stream-contain a microbial community more similar to that of biopsy samples.
Our analysis comparing patient's faecal microbiota pre-and postcolonoscopy indicates that bowel preparation does lead to changes in the faecal microbial community, but that these do not appear to occur in a co-ordinated manner. Alterations occur both at the genus and phylum level. Such differences may therefore be either due to stochastic recovery of the community after treatment or simply background noise from sampling and sequencing.
Studies by O'Brien et al (24) and Jalanka et al (25) confirm that colonoscopy preparation does not significantly affect the gut microbiota in the long term. The short-term effects of bowel preparation may be due to the majority of the bacteria being washed out in a nondiscriminatory manner, which could reduce low-abundance taxonomic groups to levels below detection; on average, bowel preparation with polyethylene glycol can reduce bacterial load by 34.7-fold (25) .
Many studies into the aetiology of CD and UC focus on the important role played by the intestinal microbiota. Our findings of the association between IBD and the gut microbiota are in accordance with previous studies. Increased abundance of Escherichia (or related Enterobacteriaceae, given to difficulty of resolving this family with 16S rRNA-based methodologies (26)) has also been found in adult patients with UC compared to healthy individuals in biopsies (27) and faecal samples (28). Maukonen et al (2) found an association between reduced Lachnospiraceae and paediatric IBD, particularly in the case of UC. In a discordant twin study, Lepage et al (3) found reduced levels of Lachnospiraceae in the UC twins. Some studies have suggested more precise microbial associations, with reductions in Roseburia (a genus of the Lachnospiraceae family) in both UC and CD (4), and in UC alone (5), compared to healthy controls. An array of both mucosal and stool-based studies has observed a reduced diversity of the microbial community in association with UC (3, 6, 29) and with both UC and CD (27) . Our observation of these factors is therefore both supported and further reinforces the utility of luminal contents from a prepared bowel as an accurate surrogate for the mucosal microbial community. These signals are not evident in samples before bowel preparation; however, suggesting that faecal material during colonoscopy (and postbowel preparation) is more representative of the mucosal layer.
The study population was comparable in size to similar studies, and provides new paediatric data, which build upon what is known from adult populations.
Although larger patient cohorts could further explore our conclusions, we provide evidence that the paediatric colonic microbiota is subject to systematic variation depending upon sample method and bowel cleansing effects, and that in pursuit of the mucosa-associated microbiota an invasive gut biopsy may not be required. Our findings support the ongoing development of the human gut microbiota as a practical tool; able to segregate patients based on disease state, and of potential utility in pathophysiological study and clinical practice.
